MetLife (MET)
NYSEFinancialsInsurance - LifeSnapshot 2026-09-04
$97.62-1.62%
Close 2026-09-04 · 1-day change
NYSEFinancialsInsurance - LifeSnapshot 2026-09-04
QuarterlyIQ Insights · MET
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How this business ranks within financials on a research-validated quality screen. As of 2026-09-04.
The screen ranks MET against its sector on four durable signals: share dilution, return on capital, free-cash-flow yield, and FCF margin. Historically the highest-quality names tended toward better typical outcomes and fewer bad years over multi-year holds (strongest at three years, modest at one), and that pattern showed up even before the price moved. It characterizes business quality, not price direction.
Each leg is a sector-relative percentile (higher is better); 4 of 4 legs were available for this name. The composite is built from these four; the raw value follows each percentile for context.
A forward quality tilt, not a price prediction, and context for your own research rather than a recommendation. Not investment advice.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Financials names rated neutral grew net income 55% of the time over the next year (vs 62% for the rest of the cohort, n=10246).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Continue to grow adjusted earnings per share at double-digit rates through underwriting, volume growth, and investment income under the New Frontier strategy.
Stated as a priority in 8 of last 8 quarters. Adjusted EPS grew from $1.96 in 2025-Q1 to $2.43 in 2026-Q2 (+24%), with full-year 2025 adjusted EPS up 10% to $8.89. Management consistently emphasized double-digit EPS growth under New Frontier, and the financials show delivering progress.
“Adjusted earnings per share increased 20% to $2.43 ... New Frontier strategy is working.”
“Adjusted earnings per share increased 23% to $2.42 ... confident in delivering against the ambitious financial targets.”
“Adjusted earnings per share, excluding total notable items, up 10% to $8.89 for full year.”
“Adjusted earnings per share, excluding total notable items, up 21% to $2.34.”
“Adjusted earnings per share $2.02, down 11% year-over-year.”
“Adjusted earnings per share $1.96, up 7% year-over-year.”
“Adjusted earnings per share $2.09, up 14% year-over-year.”
Grow variable investment income to support earnings growth, including private equity and pension risk transfer income.
Stated as a priority in 7 of last 7 quarters. Variable investment income rose from $327 million in 2025-Q1 to $518 million in 2026-Q1 (+58%), with strong private equity returns driving growth. The trajectory shows delivering progress with some quarter-to-quarter variability.
Continue disciplined capital deployment including share repurchases and dividends, supported by strong cash flow and capital position.
Stated as a priority in 6 of last 6 quarters. Shareholder returns included over $1.1 billion in 2026-Q2 and $4.4 billion in full year 2025. Holding company cash remains within target range, indicating disciplined capital allocation and consistent capital return.
Increase premiums, fees and other revenues with broad-based growth across Group Benefits, RIS, Asia, Latin America, EMEA, and MetLife Investment Management.
Stated as a priority in 8 of last 8 quarters. Premiums, fees and other revenues grew from $12.7 billion in 2025-Q2 to $13.7 billion in 2026-Q2 (+7%), with broad-based segment growth. Management consistently highlights PFO growth, and financials show delivering progress.
MetLife aims to achieve double-digit growth in adjusted earnings per share.
Over the trailing year it converted 4.01x of net income into operating cash flow. Historically, Financials names rated robust grew net income 62% of the time over the next year (vs 56% for the rest of the cohort, n=6844).
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, long-term interest rates, Fed net liquidity, real (inflation-adjusted) rates (low R² over the window).
26 material management or governance events in the past 24 months, led by capital-allocation actions. Historically, Financials names rated volatile grew net income 59% of the time over the next year (vs 56% for the rest of the cohort, n=2797).
Not investment advice. As of 2026-09-04.
“Adjusted earnings per share $1.95, down 1% year-over-year.”
“Variable investment income up 58% to $518 million, driven by higher private equity returns.”
“Variable investment income was $497 million, primarily reflecting higher private equity returns.”
“Variable investment income was $483 million, primarily reflecting higher private equity returns.”
“Variable investment income fell to $195 million, primarily driven by lower private equity returns.”
“Variable investment income increased 26% to $327 million, primarily driven by real estate and other fund returns.”
“Variable investment income was $293 million, compared to $63 million in prior year, driven by higher private equity returns.”
“Variable investment income was $162 million, compared to $179 million in prior year, driven by lower private equity returns.”
“Returned over $1.1 billion to shareholders via share repurchases and common stock dividends.”
“Returned over $1.1 billion to shareholders via share repurchases and common stock dividends.”
“Returned nearly $4.4 billion to shareholders for full year 2025.”
“Returned approximately $875 million to shareholders via share repurchases and common stock dividends.”
“Returned $1.8 billion to shareholders via share repurchases and common stock dividends.”
“Holding company cash and liquid assets of $5.1 billion at year end, above target cash buffer.”
“Premiums, fees and other revenues increased 7% to $13.7 billion with growth across every operating segment.”
“Premiums, fees and other revenues increased 5% to $14.3 billion.”
“Premiums, fees and other revenues increased 29% to $18.7 billion.”
“Premiums, fees and other revenues were $12.5 billion, flat year-over-year.”
“Premiums, fees and other revenues were $12.7 billion, down 6%.”
“Premiums, fees and other revenues increased 14% to $13.6 billion.”
“Premiums, fees and other revenues were $14.5 billion, up 6%.”
“Premiums, fees and other revenues were $12.5 billion, down 5%.”